The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.
Fiocchi, A., Pajno, G., La Grutta, S., Pezzuto, F., Incorvaia, C., Sensi, L., et al. (2005). Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 95(3), 254-258 [10.1016/S1081-1206(10)61222-7].
Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years
LA GRUTTA, Stefania;
2005-01-01
Abstract
The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
(20) Fiocchi_Annals 2005_Safety of sublingual-swallow immunotherapy in 3-7 yr children.pdf
accesso aperto
Dimensione
63.95 kB
Formato
Adobe PDF
|
63.95 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
